A notable strength of the ketamine clinical literature is the frequent inclusion of real-world treatment-resistant depression (TRD) patients who are often excluded from other clinical trials due to severity and comorbidity.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (2)

• ketamine concept
• treatment-resistant depression concept